Ovca1 regulates cell proliferation, embryonic development, and tumorigenesis
Open Access
- 26 January 2004
- journal article
- Published by Cold Spring Harbor Laboratory in Genes & Development
- Vol. 18 (3), 320-332
- https://doi.org/10.1101/gad.1162204
Abstract
Loss of OVCA1/DPH2L1 correlates with ovarian and breast cancer. To study its in vivo role, we generated Ovca1 mutant alleles in mice. Ovca1 heterozygotes spontaneously develop cancer. Ovca1 mutant mice die during embryonic development and at birth with developmental delay and defects in multiple organ systems. Cell proliferation defects were observed in Ovca1 mutant mouse embryonic fibroblasts (MEFs). p53 deficiency can rescue these Ovca1 mutant MEF proliferation defects and partially rescue Ovca1 mutant embryonic phenotypes. Furthermore, Ovca1; p53 double heterozygotes developed tumors quicker than p53 heterozygotes and with an increased carcinoma incidence. Multiple tumor burden in Ovca1 heterozygotes that were also p53 deficient was significantly higher than in p53 homozygous mutants. These in vivo findings demonstrate that Ovca1 is a tumor suppressor that can modify p53-induced tumorigenesis and suggest that it acts as a positive regulator for cell cycle progression. The close linkage of OVCA1 and p53 on human Chromosome 17 suggests that coordinated loss may be an important mechanism for the evolution of ovarian, breast, and other tumor phenotypes.Keywords
This publication has 45 references indexed in Scilit:
- Senescence, aging, and malignant transformation mediated by p53 in mice lacking the Brca1 full-length isoformGenes & Development, 2003
- Cloning, Structure, and Expression of the Mouse Ovca1 GeneBiochemical and Biophysical Research Communications, 2001
- Detailed deletion mapping suggests the involvement of a tumor suppressor gene at 17p13.3, distal to p53, in the pathogenesis of lung cancersOncogene, 1998
- Cloning and Localization of a Human Diphthamide Biosynthesis-like Protein-2 Gene,DPH2L2Genomics, 1998
- Loss of heterozygosity of a locus on 17p13.3, independent of p53, is associated with higher grades of astrocytic tumoursOncogene, 1997
- A Revision of the Lissencephaly and Miller-Dieker Syndrome Critical Regions in Chromosome 17p13.3Human Molecular Genetics, 1997
- The Tumor Suppressor Gene Brca1 Is Required for Embryonic Cellular Proliferation in the MouseCell, 1996
- Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype–phenotype correlationNature Genetics, 1995
- Tumor spectrum analysis in p53-mutant miceCurrent Biology, 1994
- Diphthamide synthesis in Saccharomyces cerevisiae: structure of the DPH2 geneGene, 1993